---
title: "\"Performance\" CARLINK TECH's annual net profit is 20.74 million RMB, a decrease of 53.3%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281287955.md"
description: "CARLINK TECH announced its full-year results for the year ended last December, with a revenue of RMB 717 million, an increase of 2.4% year-on-year. The net profit was RMB 20.74 million, a decrease of 53.3% year-on-year; earnings per share were 6 cents. No dividend was declared"
datetime: "2026-04-01T01:46:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281287955.md)
  - [en](https://longbridge.com/en/news/281287955.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281287955.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/281287955.md) | [繁體中文](https://longbridge.com/zh-HK/news/281287955.md)


# "Performance" CARLINK TECH's annual net profit is 20.74 million RMB, a decrease of 53.3%

CARLINK TECH (02531.HK) announced its full-year results for the year ended last December, with a revenue of RMB 717 million, an increase of 2.4% year-on-year. The net profit was RMB 20.74 million, a decrease of 53.3% year-on-year; earnings per share were 6 cents. No dividend was declared

### Related Stocks

- [CARLINK TECH (02531.HK)](https://longbridge.com/en/quote/02531.HK.md)

## Related News & Research

- [Zhongtai Securities Sticks to Its Buy Rating for Wasion Holdings Limited (3393)](https://longbridge.com/en/news/281141455.md)
- [COSCO Shipping Vessels Stuck in Persian Gulf Despite Iran's Assurances of Safe Passage for China Ships](https://longbridge.com/en/news/281013216.md)
- [CICC Remains a Buy on Zhongsheng Group Holdings Ltd. (0881)](https://longbridge.com/en/news/280899320.md)
- [A Look At Grand Pharmaceutical Group (SEHK:512) Valuation After 2025 Earnings Reset And New Ophthalmic Drug Approval](https://longbridge.com/en/news/280904660.md)
- [Guotai Haitong Sticks to Their Buy Rating for Zhongsheng Group Holdings Ltd. (0881)](https://longbridge.com/en/news/281307317.md)